Benefits of new drugs pose unexpected dilemmas.
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000517:prevention & control*; D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy / Q000276:immunology / Q000401:mortality*; D001509:Bed Occupancy; D018791:CD4 Lymphocyte Count; D004185:Disability Evaluation; D006233:Persons with Disabilities / Q000331:legislation & jurisprudence*; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology* / Q000401:mortality; D017320:HIV Protease Inhibitors / Q000627:therapeutic use; D006738:Hospices; D006760:Hospitalization; D006801:Humans; D007342:Insurance Benefits; D007902:Length of Stay; D015270:Mycobacterium avium-intracellulare Infection / Q000188:drug therapy; D012943:Social Security; D014481:United States
D017320:HIV Protease Inhibitors